Adulterated supplement linked to kidney failure
This article was originally published in The Tan Sheet
Executive Summary
U.K. regulatory agencies say the turmeric-based food supplement Miradin/Fortodol may contain the undeclared drug nimesulide and warn consumers against using the product. The Medicines and Healthcare products Regulatory Agency and the Food Standards Agency warn adulterated Fortodol may cause liver damage. The warnings follow an announcement by the Swedish Medical Products Agency that the product is linked to at least 11 reports of liver damage and potentially two deaths. Nimesulide is a potent anti-inflammatory drug not authorized for sale as a medicine in the U.K. The American firm Donsbach makes the supplement and exports it to Sweden where it is resold across Europe, according to the U.K. agencies
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.